Hjem › Ulcerøs colitis › Illinois
Ulcerøs colitis kliniske forsøg i Illinois
24 studier for Ulcerøs colitis søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Midwest Digestive Health & Nutrition /ID# 285250, Des Plaines
- Gi Alliance - Glenview /ID# 283932, Glenview
- Illinois Gastroenterology Group /ID# 283933, Gurnee
- og 1 flere
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Yapp, Rockford M.D. (Private Practice), Downers Grove
- GI Alliance - Glenview, Glenview
- Gastroenterology and Internal Medicine Specialists, SC, Lake Barrington
- og 3 flere
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Chicago Medical Center /ID# 271588, Chicago
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Avicenna Clinical Research - SW Gastroenterology, Oak Lawn
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 30. sep. 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 038, Chicago
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-005, Des Plaines
- Site US-007, Glenview
- Site US-020, Gurnee
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- University of Chicago Medical Center, Chicago
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06979336A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0101, Park Ridge
RekruttererFase 2/3
Alder 2 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Rush University Medical Center, Chicago
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Center for Gastrointestinal Health - Fairview Heights, Belleville
- Northwestern University, Chicago
- Midtown Gastroenterology and Liver Disease, Des Plaines
- og 2 flere
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Rush University Medical Center, Chicago
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Midwest Digestive Health & Nutrition, Des Plaines
- og 1 flere
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Chicago Medicine, Chicago
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Illinois Gastroenterology Group - Gurnee, Gurnee
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 21. aug. 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Rush University Medical Center - Site Number: 8400015, Chicago
- Midwest Digestive Health and Nutrition - Site Number: 8400136, Des Plaines
- GI Alliance - Glenview - Site Number: 8400068, Glenview
- og 1 flere
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Chicago Medicine, Chicago
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT05230173An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
- Suburban Gastroenterology Ltd, Naperville
RekruttererObservationsstudie
Alder 18 til 64 · Alle køn · Opdateret 9. jul. 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- University of Chicago Medical Center, Chicago
RekruttererFase 2
Alder 12 til 17 · Alle køn · Opdateret 8. jul. 2026 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital Park Ridge, Park Ridge
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 22. jun. 2026 · NCT06405087Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
- Northwestern University, Chicago
RekruttererFase 2
Alder 18 til 85 · Alle køn · Opdateret 22. maj 2026 · NCT07427017A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Advocate Children's Hospital - Park Ridge - PIN, Park Ridge
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT05442567STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
- University of Chicago, Chicago
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 6. apr. 2026 · NCT06693310A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Glenview
- Mirador Therapeutics Selected Site, Gurnee
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Northwestern Medicine Lake Forest Hospital, Lake Forest
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 8. jan. 2026 · NCT05987852Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.